clavulanic acid has been researched along with sulbactam in 173 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 52 (30.06) | 18.7374 |
1990's | 68 (39.31) | 18.2507 |
2000's | 29 (16.76) | 29.6817 |
2010's | 19 (10.98) | 24.3611 |
2020's | 5 (2.89) | 2.80 |
Authors | Studies |
---|---|
Hall, TW; Ishida, N; Maiti, SN; Micetich, RG; Nakai, A; Ogawa, K; Spevak, P; Tanaka, M; Yamabe, S; Yamazaki, T | 1 |
Joyeau, R; Labia, R; Molines, H; Wakselman, M | 1 |
Gottstein, WJ; Haynes, UJ; McGregor, DN | 1 |
Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN | 1 |
Anzic, B; Copar, A; Mesar, T; Prevec, T; Selic, L; Solmajer, T; Vilar, M | 1 |
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Beceiro, A; Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Pérez, A; Rodríguez-Baño, J; Vila, J | 1 |
Hesse, L; Paukner, S; Prezelj, A; Solmajer, T; Urleb, U | 1 |
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Black, MT; Bruneau, JM; Claudon, M; Coleman, K; Frère, JM; Miossec, C; Péchereau, MC; Stachyra, T | 1 |
Bethel, CR; Bonomo, RA; Caselli, E; Drawz, SM; Dwulit-Smith, JR; Papp-Wallace, KM; Prati, F; Rodkey, EA; Romagnoli, C; Smith, KM; Taracila, MA; van den Akker, F; Winkler, ML; Xu, Y | 1 |
Bethel, CR; Bonomo, RA; Buynak, JD; Carey, PR; Chai, W; Che, T; Ding, Z; Nottingham, M; Pusztai-Carey, M; Rodkey, EA; Shanmugam, S; van den Akker, F | 1 |
Bonomo, RA; Currie-McCumber, C; Shlaes, DM | 1 |
Hedberg, M; Lindqvist, L; Nord, CE; Tunér, K | 2 |
Griggs, DJ; Piddock, LJ; Traynor, EA | 1 |
Lewis, N; Liu, H | 1 |
Bawdon, RE; Dax, JB; Gilstrap, LC; Maberry, MC; Sobhi, S; Trimmer, KJ | 1 |
Aspinall, S; Corkill, JE; Hart, CA; McLennan, AG | 1 |
Cullmann, W | 2 |
Castillo, AM; Gutierrez, J; Liebana, J; Martin, MA; Piédrola, G | 1 |
Cavalieri, SJ; New, C; Sanders, CC | 1 |
Jackson, D | 1 |
Adlard, MW; Shah, AJ; Stride, JD | 1 |
Pastorek, JG | 1 |
Barthélémy, M; Kazmierczak, A; Labia, R; Morand, A; Péduzzi, J; Tiwari, K | 1 |
Cordin, X; Duez, JM; Kazmierczak, A; Pechinot, A; Siebor, E; Sirot, J | 1 |
Sutherland, R | 1 |
Aldridge, KE; Sanders, CV | 1 |
Barry, AL; Fuchs, PC | 1 |
Sanders, CC; Sanders, WE; Thomson, KS; Weber, DA | 1 |
Földes, J; Hajdu, E; Nagy, E | 1 |
Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD | 1 |
Jacobus, NV; Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
Bruckner, G; Hampel, B; Koeppe, P; Lode, H | 1 |
Adachi, K; Ueda, S; Watanabe, M; Yamabe, S | 1 |
Chin, NX; McElrath, MJ; Neu, HC | 1 |
Moosdeen, F; Williams, J; Yamabe, S | 1 |
Conner, CS | 1 |
Grimont, PA; Hornstein, MJ; Jupeau, AM; Philippon, AM; Scavizzi, MR | 1 |
Chapman, M; Colley, N; Houang, ET | 1 |
Scorneaux, B; Van der Auwera, P | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Rice, RJ; Thompson, SE | 1 |
Aldridge, KE; Marier, RL; Sanders, CV | 1 |
McDougal, LK; Thornsberry, C | 1 |
Aronoff, SC; Jacobs, MR; Johenning, S; Shlaes, DM; Yamabe, S | 1 |
Guibourdenche, M; Philippon, A; Riou, JY; Sotolongo, F | 1 |
Aronoff, SC; Jacobs, MR; Johenning, S; Yamabe, S | 2 |
Appelbaum, PC; Jacobs, MR; Spangler, SK; Yamabe, S | 1 |
Eggleston, M; Parker, RH | 1 |
Ohkawa, M | 1 |
Cynamon, MH; Sorg, TB | 1 |
Cundy, KR; Fekete, T; McGowen, J | 1 |
Ito, T; Tamura, M | 1 |
Binder, S; Cullmann, W; Stieglitz, M | 1 |
Fu, KP; Grace, ME; Gregory, FJ; Hung, PP | 1 |
Brickley, X; Duval, J; Legrand, P; Orsoni, A; Soussy, CJ | 1 |
Bush, K | 1 |
Masecar, BL; Patterson, JE; Zervos, MJ | 1 |
Barry, AL; Fuchs, PC; Jones, RN | 2 |
Grimm, H | 1 |
Bodey, GP; Bolivar, R; Weaver, SS | 1 |
Brenner, DG; Knowles, JR | 2 |
Calderwood, SB; Gardella, A; Jacoby, GA; Moellering, RC; Philippon, AM | 1 |
Belasco, JG; Charnas, RL; Fisher, J; Khosla, S; Knowles, JR | 1 |
Andrews, JM; Bedford, KA; Wise, R | 1 |
Fu, KP; Neu, HC | 2 |
Li, JT; Moosdeen, F; Williams, JD | 1 |
Baumgärtner, M; Wundt, W | 1 |
Fleck, WF; Heyn, B; Schröer, HP | 1 |
Baumgärtner, M; Müller, HP; Wundt, W | 1 |
Baumgärtner, M | 1 |
Arakawa, Y; Horii, T; Ito, H; Ohsuka, S; Ohta, M | 1 |
Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA | 1 |
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL | 1 |
Chang, SC; Hsieh, WC; Luh, KT | 1 |
Harris, EB; Hastings, RC; Prabhakaran, K; Randhawa, B | 1 |
Manzella, JP | 1 |
Bensoussan, F; Bensoussan, M; Bernard, E; Carsenti-Etesse, H; De Salvador, F; Dellamonica, P; Durant, J; Mondain, V; Pradier, C; Thabaut, A | 1 |
Fastrez, J; Marchand-Brynaert, J; Vanwetswinkel, S | 1 |
Cramp, R; Knowles, DJ; Payne, DJ; Winstanley, DJ | 1 |
Alós, JI; Gómez-Garcés, JL; Mateos, MV | 1 |
Frère, JM; Ghuysen, MF; Matagne, A | 1 |
Alos, I; Baquero, F; Baquero, MR; Blazquez, J; Canton, R | 1 |
Inoue, E; Mitsuhashi, S; Muratani, T; Nakane, T; Yokota, E | 1 |
Mentis, AF; Tsakris, A; Tzelepi, E; Tzouvelekis, LS | 1 |
Jin, YF; Piddock, LJ; Turner, HL | 1 |
Barry, A; Fuchs, P; Gerlach, E; Hardy, D; McLaughlin, J; Pfaller, M | 1 |
Gaudreau, C; Lachance, N; Lamothe, F; Turgeon, F | 1 |
Amyes, SG; Thomson, CJ | 1 |
Blatter, MM; Bluestone, CD; Chan, KH; Fall, PA; Reisinger, KS; Tan, LS | 1 |
Bohman, VR; Cox, SM; Leveno, KJ; Sherman, ML | 1 |
Farinati, AE; Fernández-Lausi, A; Jugo, MB; Villar, HE | 1 |
Labia, R; Mariotte-Boyer, S; Nicolas-Chanoine, MH | 1 |
Alós, JI; Balas, D; Cogollos, R; Gomez-Graces, JL; Tajada, P | 1 |
Amicosante, G; Bonfiglio, G; Cornaglia, G; Felici, A; Oratore, A; Perilli, M; Rossolini, GM | 1 |
Greenwood, D | 1 |
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
Klepser, ME; Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R; Zhu, Z | 1 |
Baker, PD; Fernau, R; Landon, GC; Lipsky, BA | 1 |
Diogo, MJ; Garite, TJ; Lovett, SM; Weiss, JD; Williams, PT | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Basu, D; Basu, J; Narayankumar, DV; Van Beeumen, J | 1 |
Barthélémy, M; Chaibi, EB; Farzaneh, S; Labia, R; Péduzzi, J; Sirot, D | 1 |
Calcagno, ML; Danelon, G; Gutkind, G; Mascaretti, O; Mata, EG; Power, P; Radice, M | 1 |
Amicosante, G; Cornaglia, G; Franceschini, N; Mazzariol, A; Perilli, M; Segatore, B; Setacci, D | 1 |
Anderson, V; Bonomo, RA; Knox, JR; Lin, S; Rudin, SD; Shlaes, DM; Thomas, M | 1 |
Das, B; Goel, V; Kapil, A; Pandey, A; Seth, P; Sood, S | 1 |
Jarlier, V | 1 |
Kim, KH; Park, KW; Yim, CB | 1 |
de Seny, D; Frere, JM; Galleni, M; Laraki, N; Llabres, G; Prosperi-Meys, C; Soto, RP; Valladares, MH | 1 |
González-Lama, Z; González-Martín, M; Lupiola, P; Tejedor-Junco, MT | 1 |
de la Pena, A; Derendorf, H | 1 |
Baquero, F; Cantón, R; De Rafael, L; Martínez-Ferrer, M; Oliver, A; Pérez-Vázquez, M | 1 |
Giakkoupi, P; Legakis, NJ; Tzelepi, E; Tzouvelekis, LS | 1 |
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
Aman, K; Ebihara, M; Nakagawa, Y; Shimazu, K | 1 |
Degnan, BA; Farmer, TH; Payne, DJ | 1 |
Bao, D; Fan, X; Liu, B; Zhou, L | 1 |
Kotra, LP; Levesque, RC; Mobashery, S; Sanschagrin, F; Therrien, C | 1 |
Miranda, E; Sader, HS; Sejas, L; Tosin, I | 1 |
Levesque, RC; Palzkill, T; Sanschagrin, F; Savoie, A; Voyer, N | 1 |
Niki, Y | 1 |
Mealey, KL | 1 |
Pajchel, G; Pawłowski, K; Tyski, S | 1 |
Nakano, R; Okamoto, R | 1 |
Bonomo, RA; Carey, MP; Carey, PR; Helfand, MS; Hujer, AM; Totir, MA | 1 |
Higgins, PG; Seifert, H; Stefanik, D; Wisplinghoff, H | 1 |
Høiby, N; Walther-Rasmussen, J | 1 |
Bonomo, RA; Carey, MP; Carey, PR; Helfand, MS; Padayatti, PS; Totir, MA; van den Akker, F | 1 |
Cooper, CE; Griffin, KE; Masters, PJ; Slocombe, B; Sutherland, R | 1 |
Nord, CE | 1 |
Farmer, TH; Reading, C | 1 |
Bonomo, RA; Buynak, JD; Carey, MP; Carey, PR; Helfand, MS; Sheri, A; Totir, MA | 1 |
Bonomo, RA; Distler, AM; Thomson, JM | 1 |
Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA | 1 |
Buynak, JD; Carey, PR; Kalp, M; Totir, MA | 1 |
Bethel, CR; Bonomo, RA; Drawz, SM; Ke, W; Ori, C; Prati, F; Sampson, JM; van den Akker, F | 1 |
Bethel, CR; Bonnet, R; Bonomo, RA; Distler, AM; Endimiani, A; Hujer, AM; Hujer, KM; Papp-Wallace, K; Shyr, T; Taracila, M; Thomson, JM | 1 |
Chitnis, DS; Chitnis, S; Hemvani, N; Katara, G | 1 |
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB; Vakulenko, V | 1 |
Kasap, M; Torol, S | 1 |
Conklin, BC; Hutton, RA; Li, M; Skalweit, MJ; Taracila, MA | 1 |
Beceiro, A; Bou, G; Galleni, M; García, P; Gómez-Bertomeu, F; González-López, JJ; Kerff, F; Larrosa, N; Méndez, JA; Miró, E; Navarro, F; Oliver, A; Pérez-Llarena, FJ; Zamorano, L | 1 |
Lu, J; Pang, Y; Wang, Y; Zhang, D | 1 |
Blok, A; Pannu, NS; Tassoni, R; Ubbink, M | 1 |
Furuhashi, K; Hamada, E; Ishikawa, J; Iwaizumi, M; Maekawa, M; Nagao, Y; Nagura, O; Nanba, T; Ota, Y; Yamanaka, K | 1 |
Chai, J; Chen, S; Cheng, Q; Wai Chi Chan, E; Xu, C; Zhang, R | 1 |
Cardoso, MH; Costa, BO; Franco, OL | 1 |
Fekete, T | 1 |
Antonelli, A; Cherubini, S; D'Andrea, MM; Perilli, M; Piccirilli, A; Rossolini, GM | 1 |
Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
16 review(s) available for clavulanic acid and sulbactam
Article | Year |
---|---|
Antibiotic therapy for pelvic inflammatory disease.
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Chlamydia Infections; Chlamydia trachomatis; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Gonorrhea; Humans; Pelvic Inflammatory Disease; Sulbactam; Ticarcillin | 1990 |
Overcoming enzymatic resistance in bacteria: impact on future therapy.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Chloramphenicol; Chloramphenicol O-Acetyltransferase; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enzyme Inhibitors; Sulbactam | 1990 |
The pharmacokinetics of sultamicillin.
Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Kidney Diseases; Prodrugs; Sulbactam | 1989 |
Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985.
Topics: Cephalosporins; Chlamydia Infections; Clavulanic Acid; Clavulanic Acids; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillin Resistance; Penicillins; Pharyngeal Diseases; Quinolines; Spectinomycin; Sulbactam; Syphilis; Tetracycline | 1986 |
Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Kinetics; Penicillanic Acid; Penicillin Resistance; Penicillins; Sulbactam; Ticarcillin | 1987 |
[Clinical application of beta-lactamase inhibitors on urinary tract infections].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Sulbactam; Urinary Tract Infections | 1986 |
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Penicillins; Respiratory Tract Infections; Sulbactam; Ticarcillin | 1987 |
Beta-lactamase inhibitors from laboratory to clinic.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Sulbactam | 1988 |
[Beta lactamase inhibitors, a new start of antibiotic therapy].
Topics: beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Resistance, Microbial; Humans; Kinetics; Penicillanic Acid; Sulbactam | 1982 |
Pharmacokinetic properties of beta-lactamase inhibitors.
Topics: Absorption; Aging; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Availability; Clavulanic Acid; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
[Fundamental and clinical studies on beta-lactamase inhibitors].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2001 |
Penicillins and beta-lactamase inhibitor combinations.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam | 2001 |
[beta-Lactamase-inhibitor combinations].
Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam | 2003 |
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Inhibitors; Gene Transfer, Horizontal; Monobactams; Penicillanic Acid; Penicillins; Phylogeny; Sulbactam; Tazobactam | 2004 |
Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant Bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin Kinase; Nucleotidyltransferases; Sulbactam; Tazobactam | 2020 |
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
5 trial(s) available for clavulanic acid and sulbactam
Article | Year |
---|---|
Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Sulbactam | 1993 |
Randomized investigation of antimicrobials for the prevention of preterm birth.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Female; Gestational Age; Humans; Obstetric Labor, Premature; Penicillins; Placebos; Pregnancy; Pregnancy Outcome; Sulbactam | 1996 |
Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Topics: Adult; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Cross-Over Studies; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Female; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serum Bactericidal Test; Sulbactam; Tazobactam; Ticarcillin | 1997 |
Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Clavulanic Acids; Diabetic Foot; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Penicillins; Prospective Studies; Sulbactam; Treatment Outcome | 1997 |
A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Adult; Amoxicillin; Ampicillin; Antibiotic Prophylaxis; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Prospective Studies; Sulbactam | 1997 |
152 other study(ies) available for clavulanic acid and sulbactam
Article | Year |
---|---|
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Penicillanic Acid; Sulbactam; Tazobactam; Triazoles | 1987 |
N-aryl 3-halogenated azetidin-2-ones and benzocarbacephems, inhibitors of beta-lactamases.
Topics: Azetidines; Azetines; beta-Lactamase Inhibitors; Cephalosporins; Enzyme Inhibitors; Structure-Activity Relationship | 1988 |
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(acyloxy)methyl]-2-methylpenam-3 alpha-carboxylic acid 1,1-dioxides.
Topics: Amoxicillin; Bacteria; beta-Lactamase Inhibitors; Enzyme Inhibitors; Penicillins; Structure-Activity Relationship | 1985 |
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus | 1981 |
Design, synthesis and bioactivity evaluation of tribactam beta lactamase inhibitors.
Topics: Bacillus cereus; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Dose-Response Relationship, Drug; Drug Design; Hydrolysis; Models, Molecular | 2002 |
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Genetic variability among ampC genes from acinetobacter genomic species 3.
Topics: Acinetobacter; Acinetobacter baumannii; Amino Acid Sequence; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Genes, Bacterial; Genetic Variation; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid; Spain | 2009 |
In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests | 2009 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Inhibitory Concentration 50; Molecular Structure; Spectrometry, Mass, Electrospray Ionization | 2010 |
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Circular Dichroism; Clavulanic Acid; Crystallography, X-Ray; Drug Design; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2013 |
Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Biocatalysis; Catalytic Domain; Crystallography, X-Ray; Escherichia coli; Hydrolysis; Imines; Kinetics; Microbial Sensitivity Tests; Normal Distribution; Solutions; Spectrum Analysis, Raman; Sulbactam | 2015 |
OHIO-1 beta-lactamase resistant to mechanism-based inactivators.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Molecular Sequence Data; Mutation; Penicillanic Acid; Plasmids; Sequence Homology, Nucleic Acid; Sulbactam; Tazobactam | 1992 |
Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
Topics: Bacteroides; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Clostridium; Fusobacterium nucleatum; Penicillanic Acid; Sulbactam; Tazobactam | 1992 |
Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.
Topics: Bacteria, Anaerobic; Bacteroides; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clostridium; Fusobacterium nucleatum; Penicillanic Acid; Sulbactam; Tazobactam | 1992 |
Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefpirome; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Hexosyltransferases; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus; Sulbactam | 1992 |
Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Sulbactam | 1992 |
Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Female; Fetal Blood; Humans; Placenta; Pregnancy; Regression Analysis; Sulbactam; Ticarcillin | 1992 |
Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Molecular Weight; Penicillanic Acid; Penicillin Resistance; Penicillins; Pseudomonas; Sulbactam; Tazobactam | 1991 |
Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Enterobacter cloacae; Escherichia coli; Klebsiella; Penicillanic Acid; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam; Tazobactam | 1991 |
A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Humans; Microbial Sensitivity Tests; Sulbactam | 1991 |
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Enzyme Induction; Mice; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1991 |
Evolution of beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Sulbactam | 1991 |
A sensitive assay for clavulanic acid and sulbactam in biological fluids by high-performance liquid chromatography and precolumn derivatization.
Topics: beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Sulbactam | 1990 |
Interaction of beta-lactamase inhibitors with various beta-lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Humans; Klebsiella; Penicillanic Acid; Plasmids; Proteus vulgaris; Staphylococcus aureus; Sulbactam; Tazobactam | 1990 |
Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Enzyme Induction; Microbial Sensitivity Tests; Sulbactam | 1990 |
Development of beta-lactamase inhibitors.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Drugs, Investigational; Humans; Penicillins; Sulbactam; Ticarcillin | 1990 |
In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Topics: Ampicillin; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Sulbactam; Ticarcillin | 1990 |
Implications of beta-lactamase-inhibitor combinations.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1990 |
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sulbactam; Ticarcillin | 1990 |
Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Sulbactam | 1990 |
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin | 1989 |
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 1989 |
The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture.
Topics: beta-Lactamase Inhibitors; Cell Division; Cells, Cultured; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Sulbactam; Tazobactam | 1987 |
Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Penicillanic Acid; Sulbactam | 1988 |
The activity of a sulphone beta-lactamase inhibitor, YTR 830.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillanic Acid; R Factors; Sulbactam; Tazobactam | 1987 |
beta-Lactamase inhibitors.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Sulbactam | 1985 |
In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Yersinia enterocolitica | 1985 |
Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
Topics: Adult; Amoxicillin; Ampicillin; Ascitic Fluid; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Female; Humans; Injections, Intravenous; Kinetics; Middle Aged; Pelvis; Penicillanic Acid; Peritoneum; Sulbactam | 1985 |
In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Clavulanic Acid; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1985 |
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Penicillins; Sulbactam; Ticarcillin | 1986 |
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1986 |
The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus aureus; Sulbactam | 1986 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Gram-Negative Aerobic Bacteria; Penicillanic Acid; Penicillins; Plasmids; Sulbactam; Tazobactam | 1986 |
Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Isoelectric Focusing; Microbial Sensitivity Tests; Neisseriaceae; Penicillanic Acid; Sulbactam | 1986 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Topics: Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Mezlocillin; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas; Sulbactam; Ticarcillin | 1986 |
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1986 |
Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Penicillanic Acid; Sulbactam | 1987 |
Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; Cefazolin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1987 |
[Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Humans; Kinetics; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1987 |
Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cephamycins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1987 |
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 1988 |
Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterococcus faecalis; Gentamicins; Penicillinase; Penicillins; Phenotype; R Factors; Sulbactam | 1988 |
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.
Topics: Amoxicillin; Ampicillin; Bacteria, Anaerobic; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Sulbactam | 1988 |
[In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
Topics: Ampicillin; Ampicillin Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Sulbactam | 1987 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enterobacter; Gram-Negative Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas; Sulbactam | 1984 |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Sulbactam; Tazobactam | 1984 |
Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Stability; Escherichia coli; Isoelectric Focusing; Penicillanic Acid; Spectrophotometry; Sulbactam; Tritium | 1984 |
6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Binding, Competitive; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Hydrolysis; Isomerism; Kinetics; Penicillanic Acid; Penicillin G; Spectrophotometry, Ultraviolet; Sulbactam | 1984 |
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa.
Topics: Azlocillin; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Imipenem; Penicillanic Acid; Penicillin Resistance; Pseudomonas aeruginosa; Species Specificity; Sulbactam; Thienamycins | 1982 |
Beta-lactamase inactivation by mechanism-based reagents.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Lactams; Penicillanic Acid; Sulbactam | 1980 |
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
Topics: Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam | 1980 |
Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Penicillins; Piperacillin; Sulbactam | 1980 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephaloridine; Clavulanic Acid; Hydrolysis; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1982 |
[Biological effects of coordination compounds of transitional metals. The beta-lactamase inhibitory effect of cis-platin, 2-aminopyridine palladium chloride, clavulanic acid and penicillanic acid sulfonate CP 45,899 in the nitrocefin test and Titertek/mic
Topics: Antineoplastic Agents; Bacillus cereus; beta-Lactamase Inhibitors; Cisplatin; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Organometallic Compounds; Palladium; Penicillanic Acid; Picolines; Sulbactam | 1983 |
[Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefsulodin; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Netilmicin; Penicillanic Acid; Sulbactam | 1983 |
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1983 |
Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Hydrogen-Ion Concentration; Kinetics; Penicillanic Acid; Sulbactam; Tazobactam | 1995 |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1995 |
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam | 1995 |
Influence of beta-lactamase inhibitors on the activity of oxacillin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Staphylococcus aureus; Sulbactam; Tazobactam | 1995 |
beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cell Division; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Penicillanic Acid; Streptomycin; Sulbactam; Tazobactam | 1995 |
Parenteral beta-lactamase inhibitor combinations for clinical use.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Sulbactam; Ticarcillin | 1995 |
Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Multiple; Drug Synergism; Microbial Sensitivity Tests; Selection, Genetic; Streptococcus pneumoniae; Sulbactam | 1994 |
Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases.
Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Penicillanic Acid; Sulbactam; Sulfonamides; Sulfones | 1994 |
Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.
Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Penicillanic Acid; Plasmids; Sulbactam; Tazobactam | 1994 |
[Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam].
Topics: Aged; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Penicillanic Acid; Sulbactam; Tazobactam | 1994 |
Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
Topics: Actinomycetales; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Kinetics; Lactams; Serine; Streptomyces; Sulbactam | 1993 |
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Cloning, Molecular; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Humans; Mutation; Penicillanic Acid; Phenotype; Sulbactam; Tazobactam | 1993 |
In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillinase; Plasmids; Sulbactam | 1993 |
Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Lactams; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Campylobacter coli; Clavulanic Acid; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Conjugation, Genetic; Drug Resistance, Microbial; Escherichia coli; Isoelectric Focusing; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Plasmids; Restriction Mapping; Sulbactam; Tazobactam | 1993 |
[Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Microbial Sensitivity Tests; Predictive Value of Tests; Reproducibility of Results; Sulbactam | 1996 |
A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Cephamycins; Clavulanic Acid; Clavulanic Acids; Enterobacter cloacae; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Kinetics; Molecular Structure; Penicillanic Acid; Recombinant Proteins; Substrate Specificity; Sulbactam; Tazobactam | 1996 |
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Campylobacter coli; Campylobacter jejuni; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam | 1996 |
Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Humans; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Sulbactam | 1996 |
Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests?
Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1996 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
Characterization of a beta-lactamase from Mycobacterium smegmatis SN2.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Enzyme Inhibitors; Molecular Sequence Data; Mycobacterium; Penicillanic Acid; Sequence Alignment; Substrate Specificity; Sulbactam | 1997 |
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Kinetics; Models, Molecular; Molecular Conformation; Penicillanic Acid; Protein Conformation; Sulbactam; Tazobactam | 1998 |
Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Enzyme Inhibitors; Penicillanic Acid; Sulbactam; Tazobactam | 1998 |
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Interactions; Drug Resistance, Multiple; Enzyme Inhibitors; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Penicillanic Acid; Providencia; Sulbactam; Tazobactam | 1998 |
Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Circular Dichroism; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Isoleucine; Kinetics; Methionine; Microbial Sensitivity Tests; Penicillanic Acid; Point Mutation; Protein Conformation; Sulbactam; Tazobactam | 1998 |
In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Clavulanic Acid; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Sulbactam | 1998 |
[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Haemophilus influenzae; Humans; Klebsiella; Klebsiella pneumoniae; Moraxella catarrhalis; Penicillanic Acid; Proteus vulgaris; Staphylococcus aureus; Streptococcus pneumoniae; Sulbactam; Tazobactam | 1998 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases.
Topics: beta-Lactamases; Binding Sites; Catalysis; Clavulanic Acid; Isomerism; Penicillanic Acid; Substrate Specificity; Sulbactam; Tazobactam | 1999 |
Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefoxitin; Cephamycins; Clavulanic Acid; Cloxacillin; Enterobacter cloacae; Enzyme Inhibitors; Genes, Bacterial; Microbial Sensitivity Tests; p-Chloromercuribenzoic Acid; Penicillin Resistance; Penicillins; Plasmids; Sulbactam; Sulfhydryl Reagents | 1998 |
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
Topics: Amoxicillin; Ampicillin; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Drug Therapy, Combination; Escherichia coli; Humans; Microbial Sensitivity Tests; Phenotype; Sulbactam | 1999 |
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asparagine; Aspartic Acid; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Inhibitory Concentration 50; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium tuberculosis; Penicillins; Sulbactam; Tuberculosis, Multidrug-Resistant | 1999 |
Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cell Membrane Permeability; Clavulanic Acid; Enterobacter cloacae; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Lactams; Penicillanic Acid; Periplasm; Sulbactam; Tazobactam | 1999 |
[Study on the beta-lactamases of the Escherichia coli HX88108 resistant to ceforperazon].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Sulbactam | 1998 |
Evaluation of inhibition of the carbenicillin-hydrolyzing beta-lactamase PSE-4 by the clinically used mechanism-based inhibitors.
Topics: Acylation; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbenicillin; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Escherichia coli; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Penicillanic Acid; Penicillin Resistance; Penicillinase; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thermodynamics | 2000 |
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin | 2000 |
Structure-function analysis of alpha-helix H4 using PSE-4 as a model enzyme representative of class A beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Circular Dichroism; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Recombinant Proteins; Structure-Activity Relationship; Sulbactam; Tazobactam | 2000 |
CE versus LC for simultaneous determination of amoxicillin/clavulanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clavulanic Acid; Drug Therapy, Combination; Electrophoresis, Capillary; Sulbactam | 2002 |
Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography.
Topics: Amines; Amino Acid Substitution; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Crystallization; Deuterium Oxide; Enzyme Inhibitors; Kinetics; Microscopy; Models, Molecular; Penicillanic Acid; Recombinant Proteins; Spectrum Analysis, Raman; Sulbactam; Tazobactam; Water | 2003 |
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; DNA; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 2004 |
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Binding Sites; Clavulanic Acid; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Klebsiella pneumoniae; Models, Chemical; Models, Molecular; Mutation; Penicillanic Acid; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Serine; Spectrum Analysis, Raman; Sulbactam; Tazobactam; Time Factors; X-Rays | 2005 |
Comparative activities in vitro of amoxycillin/clavulanic acid and ampicillin/sulbactam.
Topics: Amoxicillin; Animals; Bacteria; Clavulanic Acid; Drug Therapy, Combination; Haemophilus influenzae; Horses; Microbial Sensitivity Tests; Penicillin Resistance; Sulbactam | 1989 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 1989 |
The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
Topics: beta-Lactamases; Clavulanic Acid; Enzyme Induction; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam | 1989 |
Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase.
Topics: Acrylates; Amino Acid Substitution; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Crystallization; Enzyme Inhibitors; Imines; Kinetics; Molecular Structure; Penicillanic Acid; Recombinant Proteins; Serine; Spectrum Analysis, Raman; Sulbactam; Tazobactam | 2007 |
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
Topics: Amino Acid Substitution; Ampicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Kinetics; Mass Spectrometry; Molecular Structure; Plasmids; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Sulbactam | 2007 |
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam | 2008 |
Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Crystallography, X-Ray; Enzyme Inhibitors; Imines; Penicillanic Acid; Quantum Theory; Spectrum Analysis, Raman; Sulbactam; Tazobactam | 2009 |
Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
Topics: beta-Lactamase Inhibitors; Boronic Acids; Cefoperazone; Ceftazidime; Clavulanic Acid; Enzyme Inhibitors; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Penicillanic Acid; Sulbactam; Tazobactam | 2011 |
Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli Proteins; Kinetics; Meropenem; Molecular Dynamics Simulation; Molecular Structure; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam; Tazobactam; Thienamycins | 2011 |
Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Combinations; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam | 2011 |
Class A carbapenemase FPH-1 from Francisella philomiragia.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Doripenem; Ertapenem; Escherichia coli; Francisella; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam; Thienamycins | 2012 |
Purification and characterization of OXA-23 from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Dose-Response Relationship, Drug; Enzyme Activation; Escherichia coli; Kinetics; Models, Molecular; Penicillanic Acid; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Surface Properties; Tazobactam | 2013 |
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Thienamycins | 2012 |
Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Clavulanic Acid; Enterobacter cloacae; Escherichia coli; Humans; Klebsiella oxytoca; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 2014 |
In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sulbactam; Thienamycins; Tuberculosis, Multidrug-Resistant | 2016 |
New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
Topics: Acylation; Aldehydes; Amino Acid Substitution; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Crystallography, X-Ray; Mycobacterium tuberculosis; Protein Conformation; Serine; Sulbactam; Tazobactam | 2019 |
Detection of extended-spectrum β-lactamases producing Enterobacteriaceae using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry based MBT STAR-BL software module with β-lactamase inhibition assay depends on the bacterial stra
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Clavulanic Acid; Enterobacteriaceae; Humans; Hydrolysis; Microbial Sensitivity Tests; Software; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2019 |
Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Catalytic Domain; Clavulanic Acid; Crystallography; Drug Resistance, Multiple, Bacterial; Hydrolysis; Mass Spectrometry; Models, Molecular; Sulbactam | 2020 |
Fluoroquinolones vs. amoxicillin-clavulanate or ampicillin-sulbactam were not linked to aortic aneurysm or dissection.
Topics: Amoxicillin; Ampicillin; Aortic Aneurysm; Aortic Dissection; Clavulanic Acid; Dissection; Fluoroquinolones; Humans; Sulbactam | 2021 |
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Clavulanic Acid; Kinetics; Plasmids; Sulbactam; Tazobactam | 2022 |